Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $26,915 | 1,800 | 99.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $119.32 | 1 | 0.4% |
| Gift | $59.40 | 1 | 0.2% |
| Education | $36.54 | 5 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $3,972 | 277 | $0 (2024) |
| Novo Nordisk Inc | $2,311 | 193 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,996 | 90 | $0 (2024) |
| Lilly USA, LLC | $1,955 | 153 | $0 (2024) |
| ABBVIE INC. | $1,853 | 144 | $0 (2024) |
| PFIZER INC. | $1,421 | 102 | $0 (2024) |
| Amgen Inc. | $1,363 | 92 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $1,197 | 89 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,040 | 72 | $0 (2023) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $728.79 | 46 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,179 | 142 | PFIZER INC. ($606.59) |
| 2023 | $3,621 | 206 | GlaxoSmithKline, LLC. ($659.82) |
| 2022 | $3,571 | 227 | ABBVIE INC. ($433.58) |
| 2021 | $4,582 | 277 | AbbVie Inc. ($499.36) |
| 2020 | $3,735 | 246 | GlaxoSmithKline, LLC. ($534.50) |
| 2019 | $2,742 | 234 | GlaxoSmithKline, LLC. ($482.41) |
| 2018 | $2,978 | 233 | GlaxoSmithKline, LLC. ($550.13) |
| 2017 | $2,722 | 242 | GlaxoSmithKline, LLC. ($581.08) |
All Payment Transactions
1,807 individual payment records from CMS Open Payments — Page 1 of 73
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $13.58 | General |
| Category: PAIN | ||||||
| 12/17/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.69 | General |
| Category: Cardio-renal | ||||||
| 12/16/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $24.59 | General |
| Category: RESPIRATORY | ||||||
| 12/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.61 | General |
| Category: Gastroenterology | ||||||
| 12/05/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $24.36 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 12/03/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $14.39 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 12/02/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $18.63 | General |
| Category: PAIN | ||||||
| 11/29/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $111.93 | General |
| Category: Neuromodulation | ||||||
| 11/20/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: Bone Health | ||||||
| 11/19/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $15.96 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/18/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $23.84 | General |
| Category: RESPIRATORY | ||||||
| 11/14/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $19.04 | General |
| Category: PAIN | ||||||
| 11/14/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $10.32 | General |
| Category: Inflammation | ||||||
| 11/13/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: Cardio-renal | ||||||
| 11/12/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $13.46 | General |
| Category: PSYCHIATRY | ||||||
| 11/11/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $7.36 | General |
| Category: VACCINES | ||||||
| 11/08/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $103.86 | General |
| Category: Cardio-renal | ||||||
| 11/07/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $29.26 | General |
| Category: VACCINE | ||||||
| 11/05/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $27.67 | General |
| Category: VACCINES | ||||||
| 11/05/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.52 | General |
| Category: Diabetes | ||||||
| 11/04/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $19.26 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 10/31/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: PAIN | ||||||
| 10/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.75 | General |
| Category: Gastroenterology | ||||||
| 10/29/2024 | ABBVIE INC. | UBRELVY (Drug), SYNTHROID | Food and Beverage | In-kind items and services | $4.14 | General |
| Category: NEUROSCIENCE | ||||||
| 10/23/2024 | PFIZER INC. | ZAVZPRET (Drug) | Food and Beverage | In-kind items and services | $113.43 | General |
| Category: PAIN | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 355 | 564 | $70,793 | $48,811 |
| 2022 | 9 | 419 | 687 | $86,616 | $60,075 |
| 2021 | 12 | 471 | 737 | $85,673 | $61,478 |
| 2020 | 11 | 359 | 472 | $53,500 | $33,480 |
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 121 | 289 | $40,460 | $26,646 | 65.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 94 | 94 | $14,100 | $12,182 | 86.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 68 | 101 | $10,605 | $6,038 | 56.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 12 | 17 | $3,264 | $2,429 | 74.4% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2023 | 29 | 29 | $1,450 | $1,142 | 78.7% |
| G0102 | Prostate cancer screening; digital rectal examination | Office | 2023 | 19 | 19 | $779.00 | $322.32 | 41.4% |
| 81002 | Urinalysis, manual test | Office | 2023 | 12 | 15 | $135.00 | $51.15 | 37.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 127 | 360 | $50,400 | $34,593 | 68.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 95 | 95 | $14,250 | $12,603 | 88.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 70 | 98 | $10,290 | $5,740 | 55.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 16 | 21 | $4,032 | $2,570 | 63.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 32 | 32 | $4,640 | $2,550 | 55.0% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2022 | 25 | 25 | $1,250 | $988.15 | 79.1% |
| 0064A | Adm sarscov2 50mcg/0.25mlbst | Office | 2022 | 18 | 18 | $900.00 | $730.08 | 81.1% |
| G0102 | Prostate cancer screening; digital rectal examination | Office | 2022 | 16 | 16 | $656.00 | $225.09 | 34.3% |
| 81002 | Urinalysis, manual test | Office | 2022 | 20 | 22 | $198.00 | $75.65 | 38.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 102 | 282 | $39,480 | $27,231 | 69.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 70 | 134 | $14,070 | $9,386 | 66.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 66 | 66 | $9,900 | $8,924 | 90.1% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 34 | 47 | $9,024 | $6,613 | 73.3% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 39 | 39 | $2,925 | $2,480 | 84.8% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 18 | 18 | $2,610 | $1,534 | 58.8% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 11 | 11 | $2,420 | $1,353 | 55.9% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2021 | 30 | 30 | $1,500 | $1,203 | 80.2% |
| 0031A | Adm sarscov2 vac ad26 .5ml | Office | 2021 | 22 | 28 | $1,160 | $1,010 | 87.1% |
About Dr. Ashley Stiegler, M.D
Dr. Ashley Stiegler, M.D is a Family Medicine healthcare provider based in Austin, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1083676126.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ashley Stiegler, M.D has received a total of $27,130 in payments from pharmaceutical and medical device companies, with $3,179 received in 2024. These payments were reported across 1,807 transactions from 72 companies. The most common payment nature is "Food and Beverage" ($26,915).
As a Medicare-enrolled provider, Stiegler has provided services to 1,604 Medicare beneficiaries, totaling 2,460 services with total Medicare billing of $203,843. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Austin, TX
- Active Since 04/04/2006
- Last Updated 07/05/2019
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1083676126
Products in Payments
- TRELEGY ELLIPTA (Drug) $2,057
- JARDIANCE (Drug) $1,129
- NURTEC ODT (Drug) $990.77
- FARXIGA (Drug) $908.37
- Ozempic (Drug) $904.97
- TRULICITY (Drug) $774.39
- XIFAXAN (Drug) $767.32
- Kerendia (Drug) $718.50
- Aimovig (Biological) $708.34
- TRINTELLIX (Drug) $669.52
- UBRELVY (Drug) $646.65
- VRAYLAR (Drug) $641.68
- Vascepa (Drug) $597.13
- ANORO (Drug) $567.57
- EMGALITY (Drug) $530.27
- Trintellix (Drug) $522.66
- Saxenda (Drug) $490.13
- SHINGRIX (Biological) $444.97
- Rybelsus (Drug) $433.64
- LINZESS (Drug) $409.15
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Austin
Dr. Cynthia Brinson, M.d, M.D
Family Medicine — Payments: $533,082
Dr. David Wright, M.d, M.D
Family Medicine — Payments: $151,266
James Hahn, Md, MD
Family Medicine — Payments: $45,324
Rodolfo Alamia, Md, MD
Family Medicine — Payments: $44,627
Dr. Nomita Kim, Md, MD
Family Medicine — Payments: $39,549
Mr. Eric Perez, Fnp-C, FNP-C
Family Medicine — Payments: $32,768